rs56232219

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_002458.3(MUC5B):​c.15542T>C​(p.Leu5181Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0296 in 1,612,898 control chromosomes in the GnomAD database, including 904 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.025 ( 62 hom., cov: 33)
Exomes 𝑓: 0.030 ( 842 hom. )

Consequence

MUC5B
NM_002458.3 missense

Scores

14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.187

Publications

8 publications found
Variant links:
Genes affected
MUC5B (HGNC:7516): (mucin 5B, oligomeric mucus/gel-forming) This gene encodes a member of the mucin family of proteins, which are highly glycosylated macromolecular components of mucus secretions. This family member is the major gel-forming mucin in mucus. It is a major contributor to the lubricating and viscoelastic properties of whole saliva, normal lung mucus and cervical mucus. This gene has been found to be up-regulated in some human diseases, including sinus mucosa of chronic rhinosinusitis (CRS), CRS with nasal polyposis, chronic obstructive pulmonary disease (COPD) and H. pylori-associated gastric disease, and it may be involved in the pathogenesis of these diseases. [provided by RefSeq, Jul 2010]
MUC5B Gene-Disease associations (from GenCC):
  • interstitial lung disease
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0035450459).
BP6
Variant 11-1254758-T-C is Benign according to our data. Variant chr11-1254758-T-C is described in ClinVar as Benign. ClinVar VariationId is 164004.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.025 (3804/152332) while in subpopulation NFE AF = 0.0327 (2225/68016). AF 95% confidence interval is 0.0316. There are 62 homozygotes in GnomAd4. There are 1893 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 62 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MUC5BNM_002458.3 linkc.15542T>C p.Leu5181Pro missense_variant Exon 35 of 49 ENST00000529681.5 NP_002449.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MUC5BENST00000529681.5 linkc.15542T>C p.Leu5181Pro missense_variant Exon 35 of 49 5 NM_002458.3 ENSP00000436812.1

Frequencies

GnomAD3 genomes
AF:
0.0250
AC:
3805
AN:
152214
Hom.:
62
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0131
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00746
Gnomad ASJ
AF:
0.0286
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00807
Gnomad FIN
AF:
0.0691
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0327
Gnomad OTH
AF:
0.0225
GnomAD2 exomes
AF:
0.0267
AC:
6609
AN:
247776
AF XY:
0.0265
show subpopulations
Gnomad AFR exome
AF:
0.0152
Gnomad AMR exome
AF:
0.00513
Gnomad ASJ exome
AF:
0.0284
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0744
Gnomad NFE exome
AF:
0.0345
Gnomad OTH exome
AF:
0.0279
GnomAD4 exome
AF:
0.0301
AC:
44002
AN:
1460566
Hom.:
842
Cov.:
34
AF XY:
0.0295
AC XY:
21409
AN XY:
726550
show subpopulations
African (AFR)
AF:
0.0119
AC:
397
AN:
33480
American (AMR)
AF:
0.00564
AC:
252
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.0291
AC:
761
AN:
26122
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00951
AC:
820
AN:
86252
European-Finnish (FIN)
AF:
0.0726
AC:
3808
AN:
52446
Middle Eastern (MID)
AF:
0.00468
AC:
27
AN:
5764
European-Non Finnish (NFE)
AF:
0.0326
AC:
36277
AN:
1111746
Other (OTH)
AF:
0.0275
AC:
1660
AN:
60354
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
2448
4895
7343
9790
12238
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1334
2668
4002
5336
6670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0250
AC:
3804
AN:
152332
Hom.:
62
Cov.:
33
AF XY:
0.0254
AC XY:
1893
AN XY:
74498
show subpopulations
African (AFR)
AF:
0.0131
AC:
544
AN:
41584
American (AMR)
AF:
0.00745
AC:
114
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.0286
AC:
99
AN:
3466
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5188
South Asian (SAS)
AF:
0.00807
AC:
39
AN:
4830
European-Finnish (FIN)
AF:
0.0691
AC:
734
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0327
AC:
2225
AN:
68016
Other (OTH)
AF:
0.0222
AC:
47
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
184
367
551
734
918
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0286
Hom.:
200
Bravo
AF:
0.0198
TwinsUK
AF:
0.0302
AC:
112
ESP6500AA
AF:
0.0153
AC:
66
ESP6500EA
AF:
0.0321
AC:
273
ExAC
AF:
0.0278
AC:
3357
Asia WGS
AF:
0.00404
AC:
14
AN:
3478
EpiCase
AF:
0.0251
EpiControl
AF:
0.0263

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Leu5181Pro in exon 35 of MUC5B: This variant is not expected to have clinical si gnificance because it has been identified in 3.2% (273/8496) of European America n chromosomes from a broad population by the NHLBI Exome Sequencing Project (htt p://evs.gs.washington.edu/EVS; dbSNP rs56232219).

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.079
BayesDel_addAF
Benign
-0.63
T
BayesDel_noAF
Benign
-0.65
CADD
Benign
12
DANN
Benign
0.41
DEOGEN2
Benign
0.022
T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
LIST_S2
Benign
0.14
T
MetaRNN
Benign
0.0035
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.85
L
PhyloP100
-0.19
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-0.57
N
Sift
Benign
0.29
T
Vest4
0.18
ClinPred
0.00015
T
GERP RS
-0.018
Varity_R
0.066
gMVP
0.82
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs56232219; hg19: chr11-1275988; API